Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Student Bursary Fund Campaign launched: #FundAFuture and make a difference
2016-04-25

Description: Fund a Future logo Tags: Fund a Future

“The single most important investment any country can make is in its people.” – National Development Plan 2030


Video
Student Bursary Fund Campaign booklet (pdf)
Donate

South Africa’s National Development Plan states that universities play a key role in developing our nation. The cost of higher education, though, hinders most of our youth from transcending their circumstances.

In order to help increase the amount of lives transformed through higher education, the University of the Free State (UFS) launched the nation-wide Student Bursary Fund Campaign on Thursday 3 March 2016 in Cape Town.

“I believe the best way to break the cycle of poverty in South African families is to ensure that talented first-generation students gain access to high-quality university degree training,” says Prof Jonathan Jansen, Vice-Chancellor and Rector of the UFS.

Student Bursary Fund Campaign

The campaign aims to raise R100 m to fund talented, deserving students who do not have the financial means to obtain a university degree.

“Championing the Student Bursary Fund Campaign,” Prof Jansen says,“is not only a professional quest, but a deeply personal one for me. The university and I cannot do this alone, though. We need your support and generosity to change the landscape of our youth’s future.”

Your support is crucial

Can your contribution make a difference in a country – a world – filled with need? The answer resonates in the life of each student that has obtained a degree by means of funding.

The impact of your financial support reaches far beyond its monetary value. It pulls families from poverty. It sends forth experts and visionaries into the world. It sets in motion a culture of giving.

It irrevocably changes the futures of individuals, of communities, and ultimately of our country.

Contributions

Each contribution will bring us closer to our goal of R100 m.
Contributions can be deposited into the following account:
ABSA
Account number: 157 085 0721
Branch code: 632 005
Branch name: Business Bank - Bloemfontein
Swift code: ABSAZAJJ

For enquiries or further information:

T: +27(0)51 401 3966 | E: FundAFuture@ufs.ac.za | www.ufs.ac.za

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept